Expression pattern of programmed death-1 in lymphocyte-rich classical Hodgkin lymphoma according to the growth patterns

被引:0
|
作者
Go, Jai Hyang [1 ]
机构
[1] Dankook Univ, Dept Pathol, Coll Med, Cheonan, Chungnam, South Korea
关键词
Hodgkin lymphoma; lymphocyte-rich; programmed death-1; T-CELLS; MICROENVIRONMENT; MARKER; PD-1;
D O I
10.4103/0377-4929.191819
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We present a rare case of lymphocyte-rich classical Hodgkin lymphoma ( LRCHL), which exhibited different expression patterns of programmed death-1 ( PD-1) in nodular and interfollicular areas. A 57-year-old male patient presented with neck masses. Neck computed tomography showed enlargement of multiple lymph nodes in right Level II and III. Histologic examination of the excised lymph node revealed LRCHL with nodular and interfollicular patterns. Immunohistochemical analysis for PD-1 revealed a small number of weakly stained cells in the interfollicular area. PD-1 (+) cells were markedly increased in cell number and staining intensity in the nodular area and formed rosettes around the tumor cells.
引用
收藏
页码:538 / 540
页数:3
相关论文
共 50 条
  • [41] Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment
    Sasse, Stephanie
    Reddemann, Katharina
    Diepstra, Arjan
    Oschlies, Ilske
    Schnitter, Antje
    Borchmann, Sven
    Engert, Andreas
    Borchmann, Peter
    Klapper, Wolfram
    HAEMATOLOGICA, 2019, 104 (01) : E21 - E24
  • [42] Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
    Luo, Fan
    Cao, Jiaxin
    Lu, Feiteng
    Zeng, Kangmei
    Ma, Wenjuan
    Huang, Yan
    Zhang, Li
    Zhao, Hongyun
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [44] Utility of LRF/Pokemon and NOTCH1 Protein Expression in the Distinction Between Nodular Lymphocyte-Predominant Hodgkin Lymphoma and Classical Hodgkin Lymphoma
    Bohn, Olga
    Maeda, Takahiro
    Filatov, Alexander
    Lunardi, Andrea
    Pandolfi, Pier Paolo
    Teruya-Feldstein, Julie
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2014, 22 (01) : 6 - 11
  • [45] Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
    Fan Luo
    Jiaxin Cao
    Feiteng Lu
    Kangmei Zeng
    Wenjuan Ma
    Yan Huang
    Li Zhang
    Hongyun Zhao
    Cancer Cell International, 22
  • [46] Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified
    Kim, Sehui
    Kwon, Dohee
    Koh, Jiwon
    Nam, Soo Jeong
    Kim, Young A.
    Kim, Tae Min
    Kim, Chul Woo
    Jeon, Yoon Kyung
    VIRCHOWS ARCHIV, 2020, 477 (01) : 131 - 142
  • [47] Augmented expression of programmed death-1 in CD4+ T cells in patients with adult T cell Leukemia/Lymphoma
    Shimauchi, Takatoshi
    Kabashima, Kenji
    Tokura, Yoshiki
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 628 - 628
  • [48] Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified
    Sehui Kim
    Dohee Kwon
    Jiwon Koh
    Soo Jeong Nam
    Young A Kim
    Tae Min Kim
    Chul Woo Kim
    Yoon Kyung Jeon
    Virchows Archiv, 2020, 477 : 131 - 142
  • [49] Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance
    Muhamad, Hamidah
    Suksawai, Narittee
    Assanasen, Thamatorn
    Polprasert, Chantana
    Bunworasate, Udomsak
    Wudhikarn, Kitsada
    ACTA HAEMATOLOGICA, 2020, 143 (01) : 78 - 88
  • [50] Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis
    Bair, Steven M.
    Strelec, Lauren E.
    Feldman, Tatyana A.
    Ahmed, Gulrayz
    Armand, Philippe
    Shah, Nirav N.
    Singavi, Arun N.
    Reddy, Nishitha
    Khan, Nadia
    Andreadis, Charalambos
    Khoan Vu
    Huntington, Scott F.
    Giri, Smith
    Ujjanii, Chaitra
    Howlett, Christina
    Faheem, Malik
    Youngman, Matthew R.
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Schuster, Stephen J.
    Svoboda, Jakub
    ONCOLOGIST, 2019, 24 (07): : 955 - 962